These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30102418)

  • 1. Long-term outcome of primary immune-mediated thrombocytopenia in dogs.
    Simpson K; Chapman P; Klag A
    J Small Anim Pract; 2018 Nov; 59(11):674-680. PubMed ID: 30102418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003).
    Putsche JC; Kohn B
    J Am Anim Hosp Assoc; 2008; 44(5):250-7. PubMed ID: 18762561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non-associative immune-mediated thrombocytopenia: 20 cases (2008-2021).
    Spear DJ; Crouse ZJ; Kearns SA
    J Small Anim Pract; 2024 Apr; 65(4):261-269. PubMed ID: 38433454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC
    J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia.
    O'Marra SK; Delaforcade AM; Shaw SP
    J Am Vet Med Assoc; 2011 Feb; 238(3):346-52. PubMed ID: 21281218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of presumptive primary immune-mediated thrombocytopenia with mycophenolate mofetil versus cyclosporine in dogs.
    Cummings FO; Rizzo SA
    J Small Anim Pract; 2017 Feb; 58(2):96-102. PubMed ID: 28160307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of therapeutic plasma exchange in dogs with immune-mediated thrombocytopenia.
    Kopecny L; Palm CA; Naylor S; Kirby J; Cowgill LD
    J Vet Intern Med; 2020 Jul; 34(4):1576-1581. PubMed ID: 32557826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and dynamics of anti-platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia.
    Shropshire S; Dow S; Lappin M
    J Vet Intern Med; 2020 Mar; 34(2):700-709. PubMed ID: 32072705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine pemphigus foliaceus with concurrent immune-mediated thrombocytopenia.
    Kawarai S; Hisasue M; Matsuura S; Ito T; Inoue Y; Neo S; Fujii Y; Madarame H; Shirota K; Tsuchiya R
    J Am Anim Hosp Assoc; 2015; 51(1):56-63. PubMed ID: 25415212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review.
    Kristiansen PS; Nielsen LN
    Acta Vet Scand; 2021 Dec; 63(1):54. PubMed ID: 34961516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired amegakaryocytic thrombocytopenia--four cases and a literature review.
    Lachowicz JL; Post GS; Moroff SD; Mooney SC
    J Small Anim Pract; 2004 Oct; 45(10):507-14. PubMed ID: 15515801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia.
    Stikeman E; Bianco D
    J Small Anim Pract; 2024 May; 65(5):338-345. PubMed ID: 38239177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs.
    Rozanski EA; Callan MB; Hughes D; Sanders N; Giger U
    J Am Vet Med Assoc; 2002 Feb; 220(4):477-81. PubMed ID: 11860242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mediated neutropenia and thrombocytopenia in 3 giant schnauzers.
    Vargo CL; Taylor SM; Haines DM
    Can Vet J; 2007 Nov; 48(11):1159-63. PubMed ID: 18050797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ralstonia pickettii septicemia in a dog with immune-mediated thrombocytopenia.
    Herrera MA; Burkitt JM; Epstein SE; Jones ME; Moore PF; Sykes JE
    J Vet Intern Med; 2009; 23(1):182-5. PubMed ID: 19175738
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: a pilot study.
    O'Marra SK; Shaw SP; deLaforcade AM
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):126-30. PubMed ID: 22316313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
    Weingart C; Thielemann D; Kohn B
    Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic, asymptomatic thrombocytopenia in Cavalier King Charles spaniels: 11 cases (1983-1993).
    Smedile LE; Houston DM; Taylor SM; Post K; Searcy GP
    J Am Anim Hosp Assoc; 1997; 33(5):411-5. PubMed ID: 9278116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.